Stopping CGRP therapy: why migraines might come back
19 Aug 2025
What happens when patients stop anti-CGRP monoclonal antibody treatment? A recent study using the CGRP (human) ELISA kit (#A05481) revealed an unexpected finding: migraine frequency increased significantly after eight months of therapy discontinuation, even though plasma-free CGRP levels remained unchanged. This means that the worsening of migraine symptoms cannot be explained by free CGRP levels […]